Effective Phaco Time and Endothelial Cell Loss When Using Veritas

Part of paid clinical trials in ‘Aiea, Hawaii.

Sponsor
Aloha Vision Consultants
Study ID
NCT07176416
Status
Recruiting
Apply to this trial

Conditions

  • Cataract

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Veritas Vision System — DEVICE
    Veritas Vision System

Study Details

This study is a single center, prospective study of cumulative dissipated energy and endothelial cells loss per phacoemulsification procedure after successful cataract surgery. Subjects will be assessed 3 months postoperatively at a single visit. Clinical evaluations will include central corneal thickness, specular microscopy, as well as measurement of visual acuities at distance.

Key Dates

First listed
Sep 16, 2025
Start date
Oct 3, 2025
Status verified
Oct 2025
Primary completion
Oct 1, 2026
Completion
Oct 1, 2026

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Effective phaco time per phacoemulsification procedure [ Time Frame: Surgery (Day 0) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Aloha Vision Consultants‘AieaHawaii96701
Alana K Dunn
[email protected]
808-688-6898
Carlton Yuen, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in ‘Aiea, HI

By research site
Aloha Vision Consultants· ‘Aiea, HI

Related Studies